Alecensa Alectinib 150 Mg Capsules

About Alecensa Alectinib 150 Mg Capsules

Alecensa (Alectinib) 150 mg Capsules is an advanced targeted anticancer medication primarily used for the treatment of ALK-positive Non-Small Cell Lung Cancer (NSCLC). It works by inhibiting the abnormal Anaplastic Lymphoma Kinase (ALK) protein responsible for the growth and spread of cancer cells, helping slow disease progression and supporting better treatment outcomes. Alecensa is prescribed for patients with metastatic or surgically treated ALK-positive lung cancer and is taken under medical supervision.

Product Details:
Product Name: Alecensa Capsules
Generic Name: Alectinib
Strength: 150 mg
Dosage Form: Capsules
Therapeutic Category: Anti-Cancer / Targeted Therapy
Indication: ALK-positive Non-Small Cell Lung Cancer (NSCLC)
Administration: Oral use as prescribed by a healthcare professional
Storage: Store below 30C in a cool and dry place
Packaging: Available as per manufacturer packaging

Key Features:
Targeted ALK inhibitor therapy
Helps inhibit cancer cell growth and spread
Oral capsule for convenient administration
Used in advanced and metastatic NSCLC treatment
Quality-assured pharmaceutical product